Clinical trial
Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated…
NCT00428844 · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Industry · Completed
Key facts
| NCT number | NCT00428844 |
|---|---|
| Title | Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci |
| Official title | A Phase 2 Randomized Study Investigating the Safety, Efficacy and Pharmacokinetics of Daptomycin 6 mg/kg and 8 mg/kg Versus Comparator in the Treatment of Subjects Undergoing Surgical Standard of Care for Osteomyelitis Associated With an Infected Prosthetic Hip or Knee Joint Caused by Staphylococci |
| Lead sponsor | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteomyelitis |
| Intervention type | Drug |
| Interventions | daptomycin, vancomycin, teicoplanin, nafcillin, oxacillin, flucloxacillin |
| Enrollment | 75 |
| Start date | Jun 26, 2007 |
| Primary completion | Mar 26, 2010 |
| Completion | Jun 23, 2010 |
| First posted | Jan 30, 2007 |
| Last update posted | Jan 31, 2018 |
| Countries | Russia, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: